Shine-On BioMedical Co (ROCO:6926) Other Current Payables: NT$41.98 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6926 Shine-On BioMedical Co Ltd ROCO:6926
13 GF Score
Price NT$62.90
View Full Analysis

What is Shine-On BioMedical Co Other Current Payables?

Shine-On BioMedical Co ROCO:6926 -0.16% 13 Other Current Payables is NT$41.98 Mil as of Dec. 2025. GuruFocus rates ROCO:6926 with a GF Score™ of 13/100.

Shine-On BioMedical Co's Other Current Payables for the quarter that ended in Dec. 2025 was NT$41.98 Mil.

Shine-On BioMedical Co's quarterly Other Current Payables declined from Dec. 2024 (NT$39.14 Mil) to Jun. 2025 (NT$7.05 Mil) but then increased from Jun. 2025 (NT$7.05 Mil) to Dec. 2025 (NT$41.98 Mil).

Shine-On BioMedical Co's annual Other Current Payables increased from Dec. 2023 (NT$19.68 Mil) to Dec. 2024 (NT$39.14 Mil) and increased from Dec. 2024 (NT$39.14 Mil) to Dec. 2025 (NT$41.98 Mil).

Shine-On BioMedical Co Other Current Payables Related Terms

Shine-On BioMedical Co Other Current Payables Historical Data

* Premium members only.

The historical data trend for Shine-On BioMedical Co's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shine-On BioMedical Co Other Current Payables Chart

Shine-On BioMedical Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial 1.56 2.54 19.68 39.14 41.98

Shine-On BioMedical Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.68 18.19 39.14 7.05 41.98
ROCO:6926
13GF Score
Shine-On BioMedical Co Ltd ROCO:6926
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shine-On BioMedical Co Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of NT$41.98 Mil mean?
Shine-On BioMedical Co (ROCO:6926) has a Other Current Payables of NT$41.98 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Shine-On BioMedical Co and its competitors.
Is Shine-On BioMedical Co's Other Current Payables too high?
Shine-On BioMedical Co's current Other Current Payables is NT$41.98 Mil. Overall, Shine-On BioMedical Co has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Shine-On BioMedical Co's Other Current Payables compare to VRTX and REGN?
Shine-On BioMedical Co's Other Current Payables of NT$41.98 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Shine-On BioMedical Co and its competitors. Shine-On BioMedical Co's current Other Current Payables is NT$41.98 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shine-On BioMedical Co stock overvalued right now?
Shine-On BioMedical Co (ROCO:6926) has a current Other Current Payables of NT$41.98 Mil. The current Other Current Payables is NT$41.98 Mil. Shine-On BioMedical Co's overall GF Score™ is 13/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Shine-On BioMedical Co (ROCO:6926), the current Other Current Payables is NT$41.98 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shine-On BioMedical Co Business Description

Address No. 573, Taiwan Boulevard, 10th Floor, Section 2, West District, Taichung, TWN
Shine-On BioMedical Co Ltd develops drugs based on antibodies and nucleic acids. The Company researches, develops, manufactures, and distributes antibody anticancer drugs, nucleic acid anticancer drugs. The company's drug development and nucleic acid therapeutics are focused on providing patients with effective cancer treatment options.
13GF Score

Get the complete analysis for ROCO:6926

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$62.90
Price